AAAAAA
Results:
1-16
|
Results: 16
Authors:
Jeerooburkhan, N
Jones, LC
Bujac, S
Cooper, JA
Miller, GJ
Vallance, P
Humphries, SE
Hingorani, AD
Citation: N. Jeerooburkhan et al., Genetic and environmental determinants of plasma nitrogen oxides and risk of ischemic heart disease, HYPERTENSIO, 38(5), 2001, pp. 1054-1061
Authors:
Hingorani, AD
Chan, NN
Citation: Ad. Hingorani et Nn. Chan, D-lactate encephalopathy, LANCET, 358(9295), 2001, pp. 1814-1814
Authors:
Chan, NN
MacAllister, RJ
Colhoun, HM
Vallance, P
Hingorani, AD
Citation: Nn. Chan et al., Changes in endothelium-dependent vasodilatation and alpha-adrenergic responses in resistance vessels during the menstrual cycle in healthy women, J CLIN END, 86(6), 2001, pp. 2499-2504
Authors:
Hingorani, AD
Citation: Ad. Hingorani, Polymorphisms in endothelial nitric oxide synthase and atherogenesis - John French Lecture 2000, ATHEROSCLER, 154(3), 2001, pp. 521-527
Authors:
Hingorani, AD
Vallance, PJ
Citation: Ad. Hingorani et Pj. Vallance, Endothelial nitric oxide, EN CEL RE S, 7, 2000, pp. 3-29
Authors:
Vallance, P
Hingorani, AD
Ulrich, S
Citation: P. Vallance et al., Optimal age for starting lipid lowering treatment - Adjusted data do not justify a lower optimal age - Reply, BR MED J, 321(7261), 2000, pp. 638-638
Authors:
Ulrich, S
Hingorani, AD
Martin, J
Vallance, P
Citation: S. Ulrich et al., What is the optimal age for starting lipid lowering treatment? A mathematical model, BR MED J, 320(7242), 2000, pp. 1134-1140
Authors:
Hingorani, AD
Cross, J
Kharbanda, RK
Mullen, MJ
Bhagat, K
Taylor, M
Donald, AE
Palacios, M
Griffin, GE
Deanfield, JE
MacAllister, RJ
Vallance, P
Citation: Ad. Hingorani et al., Acute systemic inflammation impairs endothelium-dependent dilatation in humans, CIRCULATION, 102(9), 2000, pp. 994-999
Authors:
Hingorani, AD
Citation: Ad. Hingorani, Genes, blood pressure and pressor systems, HBK HYPERT, 20, 2000, pp. 451-468
Authors:
Hingorani, AD
Vallance, P
Citation: Ad. Hingorani et P. Vallance, Hypothesis of program is flawed - Reply, BR MED J, 318(7195), 1999, pp. 1419-1419
Authors:
Hingorani, AD
Vallance, P
Citation: Ad. Hingorani et P. Vallance, A simple computer program for guiding management of cardiovascular risk factors and prescribing, BR MED J, 318(7176), 1999, pp. 101-105
Authors:
Jia, HY
Hingorani, AD
Sharma, P
Hopper, R
Dickerson, C
Trutwein, D
Lloyd, DD
Brown, MJ
Citation: Hy. Jia et al., Association of the G(s)alpha gene with essential hypertension and responseto beta-blockade, HYPERTENSIO, 34(1), 1999, pp. 8-14
Authors:
Dickerson, JEC
Hingorani, AD
Ashby, MJ
Palmer, CR
Brown, MJ
Citation: Jec. Dickerson et al., Optimisation of antihypertensive treatment by crossover rotation of four major classes, LANCET, 353(9169), 1999, pp. 2008-2013
Authors:
Ulrich, S
Hingorani, AD
Martin, J
Vallance, P
Citation: S. Ulrich et al., Lifetime risk of developing coronary heart disease, LANCET, 353(9156), 1999, pp. 925-925
Authors:
Hingorani, AD
Liang, CF
Fatibene, J
Lyon, A
Monteith, S
Parsons, A
Haydock, S
Hopper, RV
Stephens, NG
O'Shaughnessy, KM
Brown, MJ
Citation: Ad. Hingorani et al., A common variant of the endothelial nitric oxide synthase (Glu(298)-> Asp)is a major risk factor for coronary artery disease in the UK, CIRCULATION, 100(14), 1999, pp. 1515-1520
Authors:
Bhagat, K
Hingorani, AD
Palacios, M
Charles, IG
Vallance, P
Citation: K. Bhagat et al., Cytokine-induced venodilatation in humans in vivo: eNOS masquerading as iNOS, CARDIO RES, 41(3), 1999, pp. 754-764
Risultati:
1-16
|